Vifor Fresenius Medical Care Renal Pharma and Cara Therapeutics, Inc. announced that England’s National Institute for Health and Care Excellence has recommended Kapruvia® for the treatment of moderate-to-severe CKD-associated pruritus in adult patients on haemodialysis.
GenScript’s new life-science building in Zhenjiang, Jiangsu, China spans 91,310 sq. ft. and is ISO 9001 certified; highly automated clean-room facilities offer fast-turnaround, high-purity oligonucleotide and peptide synthesis service for R&D and preclinical applications.
GenScript Expands Peptide and Oligonucleotide Production Facility in China Read More »
Asieris Pharmaceuticals, a global biopharma company specializing in discovering, developing and commercializing innovative drugs for the treatment of genitourinary tumors and other related diseases, announced a strategic collaboration with UroViu Corporation.
FzioMed, Inc., a global leading surgical biomaterials company focused on spine, orthopedic, peritoneal and gynecological surgery, announced the appointment of industry veteran Alex DiNello to its Board of Directors whose appointment became effective May 1, 2023.
FzioMed Announces Addition of Industry Veteran to its Board of Directors Read More »
CANbridge Pharmaceuticals Inc. announced that data on a novel second-generation spinal muscular atrophy gene therapy, developed under the CANbridge and UMass Chan Medical School research agreement, was presented as a poster at the American Society of Gene and Cell Therapy 26th Annual Meeting, in Los Angeles.
Cabaletta Bio, Inc. announced the pricing of an underwritten public offering of 7,250,000 shares of its common stock at a public offering price of $12.00 per share.
Cabaletta Bio Announces Pricing of Public Offering of Common Stock – May 18, 2023 Read More »
Shares of Intercept Pharmaceuticals fell 27% in mid-morning trading Wednesday after FDA briefing documents noted modest benefits versus serious risks with obeticholic acid tablets.
Intercept Shares Fall as FDA Again Questions Risk-Benefit of NASH Treatment Read More »
The findings reflect government subsidies aimed at boosting healthcare access during the pandemic, and requirements that states keep Medicaid beneficiaries on their rolls during the public health emergency.
Uninsured rate fell 18% during pandemic, CDC finds Read More »
Included’s care teams will now be able to coordinate in-home care for patients after a telehealth visit through Dispatch’s network of medical practitioners.
Included Health and DispatchHealth partner on virtual-to-in-home care Read More »
To improve price transparency, the government could consider extending reporting requirements to more provider sites or making compliance a condition of participating in Medicare, witnesses testified in a Tuesday hearing.
House Republicans target Biden admin over hospital price transparency noncompliance Read More »
